ALC - Alcon, Inc.

NYSE - NYSE Delayed Price. Currency in USD
59.48
-0.35 (-0.58%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close59.83
Open59.41
Bid59.47 x 1000
Ask59.48 x 1000
Day's Range59.41 - 59.89
52 Week Range53.78 - 63.73
Volume1,428,953
Avg. Volume1,031,682
Market Cap29.048B
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.60
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est64.80
Trade prices are not sourced from all markets
  • Benzinga

    The Daily Biotech Pulse: Acceleron Shelves Muscular Dystrophy Drug Trial, Aclaris Aces Late-Stage Study

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 16) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) Alder ...

  • Business Wire

    Alcon Prices US$2.0 Billion Senior Notes Offering

    Alcon (SIX/NYSE: ALC) announced that it has priced a private offering of US$500.0 million aggregate principal amount of its 2.75% senior notes due 2026, US$1.0 billion aggregate principal amount of its 3.0% senior notes due 2029 and US$500.0 million aggregate principal amount of its 3.8% senior notes due 2049 (the “Notes”). The Notes will be issued by Alcon Finance Corporation, Alcon’s indirect subsidiary, and will be fully and unconditionally guaranteed on a senior basis by Alcon. Alcon intends to use the proceeds from the offering to repay outstanding indebtedness and for general corporate purposes.

  • Benzinga

    The Daily Biotech Pulse: Nuvectra Explores Strategic Options, J&J To Contend Opioid Ruling, Sesen Bio Gets New CFO

    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 26) DURECT Corporation (NASDAQ: DRRX ) Stoke Therapeutics ...

  • Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens
    Business Wire

    Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens

    Alcon (SIX/NYSE:ALC), the global leader in eye care, today announced the Food and Drug Administration (FDA) approval and its initial commercial launch of AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL), the first and only trifocal lens for U.S. patients undergoing cataract surgery.

  • Business Wire

    Alcon Reports Second Quarter and First Half 2019 Results

    GENEVA-- -- Second quarter sales of $1.9 billion, an increase of 2%, or 5% constant currency Announced the launch of PRECISION1, a new daily SiHy lens designed for the mainstream market Second quarter mid-single digit growth in all product categories Reiterated full year outlook Regulatory News: Alcon , the global leader in eye care, reported its financial results for the second quarter and first half ...

  • Business Wire

    Alcon to Launch PRECISION1 Daily Disposable Contact Lenses as it Continues to Deliver on Vision Care Pipeline

    GENEVA-- -- PRECISION1 is the first mainstream daily disposable contact lens to use SMARTSURFACE Technology to deliver lasting visual performance and comfort 1 New clinical data show five times more contact lens wearers “strongly preferred” PRECISION1 vs. 1-Day ACUVUE Moist 2 Initial U.S. launch of PRECISION1 begins in September, with wide availability in early 2020   Regulatory News: Alcon, the global ...

  • Charts of Alcon Look Good
    TheStreet.com

    Charts of Alcon Look Good

    Traders could go long on the eye-care company on strength above $62 risking below $59 with a $72 price target.

  • Should You Pick Up Novartis (NVS) Before Q2 Earnings?
    Zacks

    Should You Pick Up Novartis (NVS) Before Q2 Earnings?

    Novartis AG (NVS) gained 1.1% so far in trading this week. Plus, the Swiss multinational pharmaceutical company has been on a tear since the end of April, up 18.2%. Now let's see what investors should expect heading into its Q2 2019 earnings release on Thursday.

  • New Alcon DAILIES® COLORS Contact Lenses Give Beauty Lovers Permission to Play with Their Eye Color Every Day
    Business Wire

    New Alcon DAILIES® COLORS Contact Lenses Give Beauty Lovers Permission to Play with Their Eye Color Every Day

    Alcon, the global leader in eye care, today announced the debut of DAILIES® COLORS contact lenses that combine the beauty of eye color enhancement with the convenience of a daily disposable contact lens. The new line features four colors – Mystic Blue, Mystic Gray, Mystic Hazel and Mystic Green* – introduced at a time when color contact lenses are re-emerging as an easy and creative way to express personal style.

  • Business Wire

    Alcon Takes Center Stage with Contact Lens Innovations and the iLUX® System at the 2019 Optometry’s Meeting

    Alcon, the global leader in eye care, will launch DAILIES® COLORS contact lenses at the 2019 Optometry’s Meeting, as well as give attendees a preview of PRECISION1™ contact lenses coming soon to the US. The meeting is taking place June 19-23 at the America’s Center Convention Complex (ACCC) in St. Louis, Missouri.

  • Gymnast Laurie Hernandez and Alcon Help People See Their Potential with New “Eye Can, Eye Will” Campaign
    Business Wire

    Gymnast Laurie Hernandez and Alcon Help People See Their Potential with New “Eye Can, Eye Will” Campaign

    Alcon, the global leader in eye care, is teaming up with gold- and silver-medal winning gymnast Laurie Hernandez on a new campaign that encourages people to find inspiration to visualize and achieve their goals. The “Eye Can, Eye Will” campaign is based on Laurie’s belief that personal mantras and clear, comfortable vision with DAILIES TOTAL1® contact lenses have helped her maintain the focus and enthusiasm needed to get to the top of her game. This campaign is rolling out during a pivotal time for Laurie, as she prepares to compete in next year’s games in Tokyo.

  • Alcon, Inc. (ALC) Q1 2019 Earnings Call Transcript
    Motley Fool

    Alcon, Inc. (ALC) Q1 2019 Earnings Call Transcript

    ALC earnings call for the period ending March 31, 2019.

  • Business Wire

    Alcon Reports First Quarter 2019 Trading Update

    GENEVA-- -- First quarter sales of $1.8 billion, flat to last year; an increase of 4% constant currency Healthy momentum in Surgical business, with 2% growth and 7% constant currency growth Full year 2019 outlook of 3% to 5% constant currency net sales growth and 17% to 18% core operating margin Regulatory News: Alcon , the global leader in eye care, today reported selected financial results for the ...

  • Alcon: A Secular Grower
    GuruFocus.com

    Alcon: A Secular Grower

    Alcon Inc. (ALC) is a leading eye care company. Investors may be most familiar with its Opti- Free branded contact lens solution, but it also has exposure to the surgical area. The business is divided into two segments, surgical (about 55% of sales) and vision care (45% of sales).

  • Business Wire

    Alcon to Showcase New Clinical Data, Innovative Technology at American Society of Cataract and Refractive Surgery 2019 Annual Meeting

    GENEVA-- -- Large scientific program will reinforce the ongoing clinical and patient benefits of its robust portfolio Highlights include new product launches in phacoemulsification, visualization for the Cataract Refractive Suite and innovations in intraoperative aberrometry and AT-IOLs Onsite events for surgeons demonstrate Alcon’s continued commitment to world-class training, education Alcon, the ...